Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Zielinski

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Wiener Klinische Wochenschrift|January 1, 1991
[Intravenous substitution with immunoglobulins]C C Zielinski, M M Eibl
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2020
Reply to Third consensus on medical treatment of metastatic breast cancerW J Köstler, C C Zielinski,
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancerC G Mitter, C C Zielinski
Arthritis and Rheumatism|July 1, 1984
Inhibition of natural killer cell activity by fibronectinC C Zielinski, H P Schwarz
Journal of the National Cancer Institute|January 16, 1999
Inhibition of metastases by anticoagulantsM Hejna, M Raderer, C C Zielinski
Digestive Diseases and Sciences|March 1, 1993
Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitisC Müller, P Knoflach, C C Zielinski
Clinical Immunology and Immunopathology|October 1, 1990
Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritisC C Zielinski, B Pesau, C Müller
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Local use of GM-CSF for severe mucositisM Hejna, T Brodowicz, C C Zielinski
Gastroenterology|March 1, 1990
T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cellsC Mueller, P Knoflach, C C Zielinski
Hepatology (Baltimore, Md.)|December 1, 1989
Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver diseaseC Müller, P Knoflach, C C Zielinski
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Wiener Klinische Wochenschrift|January 1, 1991
[Intravenous substitution with immunoglobulins]C C Zielinski, M M Eibl
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2020
Reply to Third consensus on medical treatment of metastatic breast cancerW J Köstler, C C Zielinski,
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancerC G Mitter, C C Zielinski
Arthritis and Rheumatism|July 1, 1984
Inhibition of natural killer cell activity by fibronectinC C Zielinski, H P Schwarz
Journal of the National Cancer Institute|January 16, 1999
Inhibition of metastases by anticoagulantsM Hejna, M Raderer, C C Zielinski
Digestive Diseases and Sciences|March 1, 1993
Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitisC Müller, P Knoflach, C C Zielinski
Clinical Immunology and Immunopathology|October 1, 1990
Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritisC C Zielinski, B Pesau, C Müller
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Local use of GM-CSF for severe mucositisM Hejna, T Brodowicz, C C Zielinski
Gastroenterology|March 1, 1990
T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cellsC Mueller, P Knoflach, C C Zielinski
Hepatology (Baltimore, Md.)|December 1, 1989
Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver diseaseC Müller, P Knoflach, C C Zielinski
Pageof 16